Literature DB >> 7550536

The acylation stimulating protein-adipsin system.

K Cianflone1, M Maslowska, A Sniderman.   

Abstract

Considerable evidence indicates that obesity, and in particular abdominal obesity, is a risk factor for both heart disease and non-insulin dependent diabetes mellitus. In spite of this, little is known of the regulation of triacylglycerol synthesis in adipose tissue other than by insulin. Acylation stimulating protein (ASP), a human plasma protein, stimulates triacylglycerol synthesis in adipose tissue and is also produced by human adipocytes. ASP may play a physiological role in the regulation of efficiency of adipose tissue fat storage and affect clearance of triglycerides from plasma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550536

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  4 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

Review 2.  Emerging paradigms for understanding fatness and diabetes risk.

Authors:  Steven R Smith; Eric Ravussin
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

3.  Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: novel placental secretion via Hofbauer cells.

Authors:  K Sivakumar; M F Bari; A Adaikalakoteswari; S Guller; M O Weickert; H S Randeva; D K Grammatopoulos; C C Bastie; M Vatish
Journal:  J Clin Endocrinol Metab       Date:  2013-08-16       Impact factor: 5.958

4.  A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

Authors:  B E Aouizerat; H Allayee; R M Cantor; R C Davis; C D Lanning; P Z Wen; G M Dallinga-Thie; T W de Bruin; J I Rotter; A J Lusis
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.